221 related articles for article (PubMed ID: 38628627)
1. Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review).
Xia T; Zhu R
Biomed Rep; 2024 May; 20(5):82. PubMed ID: 38628627
[TBL] [Abstract][Full Text] [Related]
2. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer.
Wu J; Xiao Z; Li H; Zhu N; Gu J; Wang W; Liu C; Wang W; Qin L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884547
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
Zhou DZ; Sun HY; Yue JQ; Peng Y; Chen YM; Zhong ZJ
Free Radic Res; 2017 May; 51(5):517-528. PubMed ID: 28482716
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
[TBL] [Abstract][Full Text] [Related]
5. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway.
Li X; Wang X; Wang B; Chi W; Li Z; Zhang M; Shen Y; Liu X; Lu Y; Liu Y
Phytomedicine; 2022 May; 99():154027. PubMed ID: 35278898
[TBL] [Abstract][Full Text] [Related]
6. Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway.
Guo T; Wang X; Zhang G; Xia T; Zhu R; Tou J
Front Oncol; 2023; 13():1160548. PubMed ID: 37256172
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Jiang L; Zhang Q; Ren H; Ma S; Lu C; Liu B; Liu J; Liang J; Li M; Zhu R
PLoS One; 2015; 10(4):e0124994. PubMed ID: 25915649
[TBL] [Abstract][Full Text] [Related]
8. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin.
Xu Y; Wang S; Chan HF; Lu H; Lin Z; He C; Chen M
Sci Rep; 2017 Apr; 7():46060. PubMed ID: 28436480
[TBL] [Abstract][Full Text] [Related]
10. Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells.
Wang X; Hu H; Hu B; Xia H; Cheng X; Zheng J; Zhang Z; Liu H
Mol Biol Rep; 2023 Feb; 50(2):1403-1414. PubMed ID: 36474061
[TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin attenuates palmitic acid-induced oxidative stress by promoting autophagy via SIRT3-ATG4B signaling in hepatocytes.
Huang L; Zeng X; Li B; Wang C; Zhou M; Lang H; Yi L; Mi M
Nutr Metab (Lond); 2021 Sep; 18(1):83. PubMed ID: 34503544
[TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells.
Liu J; Shu Y; Zhang Q; Liu B; Xia J; Qiu M; Miao H; Li M; Zhu R
Oncol Lett; 2014 Oct; 8(4):1645-1651. PubMed ID: 25202384
[TBL] [Abstract][Full Text] [Related]
13. The Molecular Mechanism Underlying the Therapeutic Effect of Dihydromyricetin on Type 2 Diabetes Mellitus Based on Network Pharmacology, Molecular Docking, and Transcriptomics.
Wen X; Lv C; Zhou R; Wang Y; Zhou X; Qin S
Foods; 2024 Jan; 13(2):. PubMed ID: 38275711
[TBL] [Abstract][Full Text] [Related]
14. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways.
Xia J; Guo S; Fang T; Feng D; Zhang X; Zhang Q; Liu J; Liu B; Li M; Zhu R
Food Chem Toxicol; 2014 Apr; 66():7-13. PubMed ID: 24444546
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin confers cerebroprotection against subarachnoid hemorrhage via the Nrf2-dependent Prx2 signaling cascade.
Li XJ; Pang C; Peng Z; Zhuang Z; Lu Y; Li W; Zhang HS; Zhang XS; Hang CH
Phytomedicine; 2023 Oct; 119():154997. PubMed ID: 37523836
[TBL] [Abstract][Full Text] [Related]
16. Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
Zeng G; Liu J; Chen H; Liu B; Zhang Q; Li M; Zhu R
Oncol Rep; 2014 Jun; 31(6):2713-9. PubMed ID: 24789439
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis inhibition effect of Dihydromyricetin against UVA-exposed human keratinocyte cell line.
He Z; Zhang L; Zhuo C; Jin F; Wang Y
J Photochem Photobiol B; 2016 Aug; 161():40-9. PubMed ID: 27208745
[TBL] [Abstract][Full Text] [Related]
18. Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect.
Zhou X; Yu L; Zhou M; Hou P; Yi L; Mi M
Nutr Metab (Lond); 2021 Jun; 18(1):64. PubMed ID: 34147124
[TBL] [Abstract][Full Text] [Related]
19. Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.
Chou CH; Lu KH; Yang JS; Hsieh YH; Lin CW; Yang SF
Phytomedicine; 2021 Sep; 90():153642. PubMed ID: 34265701
[TBL] [Abstract][Full Text] [Related]
20. Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges.
Zhang R; Zhang H; Shi H; Zhang D; Zhang Z; Liu H
Drug Deliv; 2022 Dec; 29(1):3052-3070. PubMed ID: 36146939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]